Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Life information rehabilitation therapy
- Development stage
- Unknown
- Lead developer
- Fuda Cancer Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Life information rehabilitation therapy is a treatment approach used primarily in cancer care. It is administered orally as a solution (one bottle each day) for a consecutive period of 3 months. This therapy is often used in combination with cancer ablation techniques for treating various unresectable cancers, including gastric, lung, liver, and intestinal cancers. Clinical trials investigating this therapy have been conducted at Fuda Cancer Hospital in Guangzhou, China.
- Brand names
- Qilisheng
- Other names
- Life information rehabilitation therapyQilisheng Oral Solution
Beyond the preview
Go deeper on Life information rehabilitation therapy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Life information rehabilitation therapy.